• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

定义COVID-19中儿童多系统炎症综合征和过度炎症的临床及实验室指标:一项三级医院的横断面研究

Clinical and laboratory markers defining MIS-C and hyperinflammation in COVID-19: a cross-sectional study in a tertiary hospital.

作者信息

Vieira Ana Paula Radünz, Carvalho Paulo Roberto Antonaccio, Machado Sandra Helena, da Rocha Taís Sica

机构信息

Pediatric Rheumatology Division, Federal University of Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos Street, 2350 - Santa Cecília, Porto Alegre City, Rio Grande do Sul, 90035-903, Brazil.

Pediatric Intensive Care Division, Federal University of Rio Grande do Sul, Hospital de Clínicas de Porto Alegre, Ramiro Barcelos Street, 2350 - Santa Cecília, Porto Alegre City, Rio Grande do Sul, 90035-903, Brazil.

出版信息

Adv Rheumatol. 2025 Mar 17;65(1):16. doi: 10.1186/s42358-025-00447-6.

DOI:10.1186/s42358-025-00447-6
PMID:40097994
Abstract

BACKGROUND

Numerous inflammatory complications related to COVID are described, including the Multisystem inflammatory Syndrome in Children (MIS-C) and Hyperinflammation. There is a scarcity of studies comparing these two groups.

METHODS

Retrospective longitudinal outcome-conditioned study. Demographic, clinical, and laboratory variables are analyzed. Patients with history of COVID contact or infection with at least 24 h of fever, two or more systems involved and up to 21 years were included. Patients with no laboratory signal of inflammation or with other diagnoses for the condition were excluded. Demographic and laboratory data are presented as medians with interquartile ranges. Dichotomous variables and prevalences are reported as percentages. A ROC curve analysis was conducted to assess the discriminatory ability of these tests in relation to the MIS-C and hyperinflammation groups.

RESULTS

We present fifty-four patients, thirty-one with MIS-C and twenty-three with hyperinflammation. The most frequent symptom in the MIS-C group was altered mental status in 61% vs. 46% (p = 0.014) and conjunctival hyperemia in 29% vs. 4% (p = 0.032). The most frequent laboratory findings were hypoalbuminemia in 68% vs. 26% (p = 0.002), increased serum troponin in 42% vs. 26% (p = 0.034), increased d-dimers in 94% vs. 76% (p = 0.015), as well as increased BNP in 55% vs. 17% (p = 0.02). On the other hand, the hyperinflammation group more frequently presented respiratory dysfunction in 57% vs. 13% (p = < 0.001) and serum ferritin equal or greater than 500 ng/mL in 94% vs. 77% (p = 0.046).

CONCLUSIONS

This is an original study comparing clinical and laboratory findings between MIS-C and hyperinflammation due to COVID. Altered mental status is more frequently associated with MIS-C while respiratory symptoms are associated with hyperinflammation. In addition, regarding laboratory tests, there is hypoalbuminemia, increase in serum troponin, BNP, and D-dimers specially in the MIS-C group and hyperferritinemia in the hyperinflammation group. Further studies are needed to assess the cutoff point of biological markers such as BNP, troponin, and d-dimers for diagnosis and/or prognosis in the pediatric population with MIS-C.

摘要

背景

已描述了许多与新冠病毒相关的炎症并发症,包括儿童多系统炎症综合征(MIS-C)和炎症风暴。比较这两组的研究较少。

方法

回顾性纵向结局条件研究。分析人口统计学、临床和实验室变量。纳入有新冠病毒接触史或感染史、至少发热24小时、累及两个或更多系统且年龄在21岁以下的患者。排除无炎症实验室指标或有其他病症诊断的患者。人口统计学和实验室数据以中位数及四分位间距表示。二分变量和患病率以百分比报告。进行ROC曲线分析以评估这些检测对MIS-C组和炎症风暴组的鉴别能力。

结果

我们纳入了54例患者,其中31例为MIS-C,23例为炎症风暴。MIS-C组最常见的症状是精神状态改变,占61%,而炎症风暴组为46%(p = 0.014);结膜充血在MIS-C组为29%,炎症风暴组为4%(p = 0.

相似文献

1
Clinical and laboratory markers defining MIS-C and hyperinflammation in COVID-19: a cross-sectional study in a tertiary hospital.定义COVID-19中儿童多系统炎症综合征和过度炎症的临床及实验室指标:一项三级医院的横断面研究
Adv Rheumatol. 2025 Mar 17;65(1):16. doi: 10.1186/s42358-025-00447-6.
2
Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: A meta-analysis.COVID-19 患儿中多系统炎症综合征(MIS-C)的心脏标志物:一项荟萃分析。
Am J Emerg Med. 2021 Nov;49:62-70. doi: 10.1016/j.ajem.2021.05.044. Epub 2021 May 18.
3
Acute Cardiovascular Manifestations in 286 Children With Multisystem Inflammatory Syndrome Associated With COVID-19 Infection in Europe.欧洲 286 例 COVID-19 感染相关儿童多系统炎症综合征的急性心血管表现。
Circulation. 2021 Jan 5;143(1):21-32. doi: 10.1161/CIRCULATIONAHA.120.050065. Epub 2020 Nov 9.
4
Multisystem Inflammatory Syndrome in Children (MIS-C) in a Lithuanian Paediatric Tertiary Care Center.儿童多系统炎症综合征(MIS-C)在立陶宛儿科三级保健中心的表现。
Medicina (Kaunas). 2024 Oct 30;60(11):1774. doi: 10.3390/medicina60111774.
5
Evaluation of clinical and laboratory findings in MIS-C patients associated with COVID-19: An experience from the Northwest of Iran.评估与 COVID-19 相关的 MIS-C 患者的临床和实验室检查结果:来自伊朗西北部的经验。
PLoS One. 2024 Nov 21;19(11):e0313843. doi: 10.1371/journal.pone.0313843. eCollection 2024.
6
Factors linked to severe outcomes in multisystem inflammatory syndrome in children (MIS-C) in the USA: a retrospective surveillance study.美国儿童多系统炎症综合征(MIS-C)严重结局相关因素:一项回顾性监测研究。
Lancet Child Adolesc Health. 2021 May;5(5):323-331. doi: 10.1016/S2352-4642(21)00050-X. Epub 2021 Mar 10.
7
Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.儿童严重急性呼吸综合征冠状病毒 2 诱导的多系统炎症综合征的独特临床和免疫学特征。
J Clin Invest. 2020 Nov 2;130(11):5942-5950. doi: 10.1172/JCI141113.
8
Identifying pediatric patients with multisystem inflammatory syndrome in children presenting to a pediatric emergency department.识别前往儿科急诊科就诊的患有儿童多系统炎症综合征的儿科患者。
Am J Emerg Med. 2022 Jan;51:69-75. doi: 10.1016/j.ajem.2021.10.011. Epub 2021 Oct 11.
9
Molecular Mechanisms and Pathophysiology of Myocardial Disease: Insights from Pediatric Inflammatory Multisystem Syndrome (PIMS) Associated with SARS-CoV-2.心肌病的分子机制与病理生理学:来自与SARS-CoV-2相关的儿童炎症性多系统综合征(PIMS)的见解
Int J Mol Sci. 2025 Apr 10;26(8):3580. doi: 10.3390/ijms26083580.
10
The inflammatory markers of multisystem inflammatory syndrome in children (MIS-C) and adolescents associated with COVID-19: A meta-analysis.与 COVID-19 相关的儿童(MIS-C)和青少年多系统炎症综合征的炎症标志物:一项荟萃分析。
J Med Virol. 2021 Jul;93(7):4358-4369. doi: 10.1002/jmv.26951. Epub 2021 Apr 1.

引用本文的文献

1
Clinical Characteristics and Outcomes in Multisystemic Inflammatory Syndrome in Children (MIS-C) Associated with COVID-19: A 12-Month Prospective Study.儿童多系统炎症综合征(MIS-C)与新型冠状病毒肺炎(COVID-19)相关的临床特征及预后:一项为期12个月的前瞻性研究
Microorganisms. 2025 Jun 16;13(6):1405. doi: 10.3390/microorganisms13061405.

本文引用的文献

1
Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review.新冠病毒感染儿童和儿童多系统炎症综合征中的血栓栓塞并发症:一项叙述性综述。
Front Pediatr. 2022 Aug 11;10:944743. doi: 10.3389/fped.2022.944743. eCollection 2022.
2
Overweight and obesity as risk factors for COVID-19-associated hospitalisations and death: systematic review and meta-analysis.超重和肥胖作为2019冠状病毒病相关住院和死亡的风险因素:系统评价和荟萃分析
BMJ Nutr Prev Health. 2022 Jan 19;5(1):10-18. doi: 10.1136/bmjnph-2021-000375. eCollection 2022.
3
Heart Involvement in Multisystem Inflammatory Syndrome, Associated With COVID-19 in Children: The Retrospective Multicenter Cohort Data.
儿童多系统炎症综合征中的心脏受累与 COVID-19 的关系:回顾性多中心队列数据
Front Pediatr. 2022 Mar 2;10:829420. doi: 10.3389/fped.2022.829420. eCollection 2022.
4
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 3.美国风湿病学会儿童 COVID-19 相关 SARS-CoV-2 与儿童多系统炎症综合征及过度炎症的临床指导:第 3 版
Arthritis Rheumatol. 2022 Apr;74(4):e1-e20. doi: 10.1002/art.42062. Epub 2022 Feb 3.
5
Mortality and clinical characteristics of multisystem inflammatory syndrome in children (MIS-C) associated with covid-19 in critically ill patients: an observational multicenter study (MISCO study).与 COVID-19 相关的危重症患儿多系统炎症综合征(MIS-C)的死亡率和临床特征:一项观察性多中心研究(MISCO 研究)。
BMC Pediatr. 2021 Nov 18;21(1):516. doi: 10.1186/s12887-021-02974-9.
6
A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling.基于嘌呤能信号转导的新型 COVID-19 过度炎症反应定义和治疗方法。
Purinergic Signal. 2022 Mar;18(1):13-59. doi: 10.1007/s11302-021-09814-6. Epub 2021 Nov 10.
7
Cardiac Manifestations of Multisystem Inflammatory Syndrome in Children (MIS-C) Following COVID-19.儿童多系统炎症综合征(MIS-C)与 COVID-19 后的心脏表现。
Curr Cardiol Rep. 2021 Oct 1;23(11):168. doi: 10.1007/s11886-021-01602-3.
8
Severe SARS-CoV-2 Infection Inhibits Fibrinolysis Leading to Changes in Viscoelastic Properties of Blood Clot: A Descriptive Study of Fibrinolysis in COVID-19.严重的严重急性呼吸系统综合征冠状病毒 2 型感染抑制纤溶导致血栓的黏弹性特性发生变化:COVID-19 中纤溶的描述性研究。
Thromb Haemost. 2021 Nov;121(11):1417-1426. doi: 10.1055/a-1400-6034. Epub 2021 Apr 30.
9
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.美国风湿病学会儿童与 SARS-CoV-2 相关的多系统炎症综合征和儿科 COVID-19 中过度炎症的临床指导:第 2 版。
Arthritis Rheumatol. 2021 Apr;73(4):e13-e29. doi: 10.1002/art.41616. Epub 2021 Feb 15.
10
Multisystem inflammatory syndrome in children (MIS-C) during SARS-CoV-2 pandemic in Brazil: a multicenter, prospective cohort study.巴西严重急性呼吸综合征冠状病毒 2 流行期间儿童多系统炎症综合征(MIS-C):一项多中心、前瞻性队列研究。
J Pediatr (Rio J). 2021 May-Jun;97(3):354-361. doi: 10.1016/j.jped.2020.10.008. Epub 2020 Nov 9.